Concepedia

Serine–arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer

A Mavrou, Karen Brakspear, Maryam Hamdollah‐Zadeh, Gopinath Damodaran, Roya Babaei‐Jadidi, Jon Oxley, David Gillatt, Michael Ladomery, SJ Harper, David O. Bates,

Oncogene · 2014 · 165 citations · 31 references

DOIFull text

Open access

Concepts

References

31

Cancer statistics, 2013

Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2013 · 11.9K citations · Full text

, , +16

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Howard I. Scher, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2012 · 4.6K citations · Full text

, , +14

ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS

Judah Folkman, Ezio Merler, Charles M. Abernathy et al. · The Journal of Experimental Medicine · 1971 · 1.7K citations · Full text

, , +15

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Noel Weidner, Peter R. Carroll, Jonathan Flax et al. · PubMed · 1993 · 1.6K citations

, , +14

VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.

Tai-Gen Cui, Joanne M. Doughty, Marto Sugiono et al. · PubMed · 2002 · 556 citations

, , +17